Pearl Cohen represented Immune Pharmaceuticals Inc. in its transaction to acquire the rights to Ceplene from Meda A.B., now part of Mylan, a global healthcare company….
Immune Pharmaceuticals Inc.’s Acquisition of the rights to Ceplene from Meda A.B.
![](https://globallegalchronicle.com/wp-content/uploads/2017/06/82bbbe15f0.jpeg)